Composition
- Active ingredients
- DAPAGLIFLOZIN 5MG; SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DAPAGLIFLOZIN 5MG; SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE · TabletThis page
- DAPAGLIFLOZIN 10MG; SAXAGLIPTIN HYDROCHLORIDE EQ 5MG BASE · TabletNDA209091-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA209091.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Qtern
- Active substance
- dapagliflozin
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Astrazeneca AB
- Status
- Discontinued
- FDA approval
- 27 Feb 2017
- Application
- NDA209091-002